Introduction: A1762T/
G1764A (TA) mutations in the
core promoter, which overlap with the
HBx gene, are found commonly in
HCC and are independent risk factors for the progression of
HCC during
chronic HBV infection.12 In vivo studies suggest that the TA mutant increases the replication capacity of HBV and suppresses
HBeAg serum levels.13
A1762T/
G1764A mutations are also predictors of postoperative survival in patients with HBV-related
HCC.14
A1762T/
T1764A<